Andrius Žučenka: Congratulations to All the Investigators Involved in the PARADIGM trial
Andrius Žučenka, Assistant professor at Vilniaus universitetas / Vilnius University, shared a post on LinkedIn:
“First and foremost, huge congratulations to all the investigators and everyone involved in the Paradigm trial, the hottest acute myeloid leukemia (AML) topic at the American Society of Hematology 2025. King 7+3 took a massive blow. But has lord HMA+Ven truly won?
Before reading further I sincerely recommend listening to the most recent Wolverheme podcast.
Bernard Marini and Anthony Perissinotti superbly analyzed the presented abstract in such great detail, that there’s no point for me to go through specific trial data here, (KUDOS, guys). I want to simply present my few thoughts from a general/our center’s perspective.”
Read full paper here.
Get the latest updates on Hemostasis Today.
-
Jan 31, 2026, 16:35IV Thrombolysis Does Not Improve Vision in Acute CRAO: Ahmed Koriesh on TenCRAOS Study
-
Jan 31, 2026, 16:24Joyce John Chalakkal: The Dangerous Area of The Face….
-
Jan 31, 2026, 16:04Rayya Saadiq Reflects On Qatar Health Congress 2026
-
Jan 31, 2026, 15:12Amar Raval on Oral Thin Film Drug Delivery Systems for Thrombosis Therapy
-
Jan 31, 2026, 14:40Heghine Khachatryan on WFH’s Call to Advance Health Equity for People with Bleeding Disorders
-
Jan 31, 2026, 14:10Emilia Arturo: Snake Venom, Clotting, and CryoEM!
-
Jan 31, 2026, 08:13Ming Y Lim On The Value of National Mentorship
-
Jan 31, 2026, 06:37Christian Schulze Presents The Post-Hoc Analysis of the DanGer Shock Trial
-
Jan 31, 2026, 06:27Negative Trials Matter: Anne Hege Aamodt Shares The TenCRAOS Trial